SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-19-000243
Filing Date
2019-11-13
Accepted
2019-11-13 16:05:24
Documents
42
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 sangui10q20190930vedgar3.htm 10-Q 339699
2 sangui10q20190930audit20191.jpg GRAPHIC 10100
3 sangui10q20190930audit20192.jpg GRAPHIC 19026
4 sangui10q20190930audit20193.jpg GRAPHIC 58176
5 exhibit31.01.htm EX-31 7693
6 exhibit31.02.htm EX-31 8183
7 exhibit32.01.htm EX-32 4305
  Complete submission text file 0001551163-19-000243.txt   1849061

Data Files

Seq Description Document Type Size
8 sgbi-20190930.xml EX-101.INS 224900
9 sgbi-20190930.xsd EX-101.SCH 19655
10 sgbi-20190930_cal.xml EX-101.CAL 37397
11 sgbi-20190930_def.xml EX-101.DEF 56857
12 sgbi-20190930_lab.xml EX-101.LAB 160767
13 sgbi-20190930_pre.xml EX-101.PRE 126867
Mailing Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025
Business Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025 011 49 (40) 6093120
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 191213946
SIC: 2834 Pharmaceutical Preparations